Glaxo says cervical cancer vaccine works for longer (Reuters)

[riky]

Glaxo says cervical cancer vaccine works for longer
    (Reuters)

 


Reuters - GlaxoSmithKline said on Wednesday new
data showed its Cervarix vaccine generated sustained, high
levels of neutralizing antibodies against the two most common
cervical cancer-causing virus types for 6.4 years.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080514/hl_nm/glaxosmithkline_cervarix_dc